CR

CREEK & RIVER Co.,Ltd.

A creator agency connecting professionals in creative, tech, medical, and legal sectors.

4763 | T

Overview

Corporate Details

ISIN(s):
JP3269700005
LEI:
Country:
Japan
Address:
港区新橋四丁目1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CREEK & RIVER Co., Ltd. is a multifaceted professional agency that pioneered the "creator agency" business model in Japan. The company specializes in connecting its extensive network of skilled professionals with businesses across various industries for staffing, outsourcing, and consulting projects. While its origins and strengths lie in creative fields—including video, games, web, and advertising—the firm has expanded its services to encompass a diverse range of professional sectors such as medicine, law, accounting, architecture, and advanced technology like AI and XR. In addition to its core agency business, CREEK & RIVER provides content production and rights management services, leveraging its diverse talent pool to drive innovation for its partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-10 05:17
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-10-10 05:17
Interim Report
半期報告書-第36期(2025/03/01-2026/02/28)
Japanese 241.2 KB
2025-06-02 09:46
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-05-30 08:22
Post-Annual General Meeting Information
臨時報告書
Japanese 26.5 KB
2025-05-30 08:21
Governance Information
内部統制報告書-第35期(2024/03/01-2025/02/28)
Japanese 22.4 KB
2025-05-30 08:20
Registration Form
確認書
Japanese 8.2 KB
2025-05-30 08:19
Annual Report
有価証券報告書-第35期(2024/03/01-2025/02/28)
Japanese 2.9 MB
2025-05-01 09:13
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-04-01 09:27
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-03-21 07:58
Regulatory News Service
臨時報告書
Japanese 28.6 KB
2025-03-04 03:46
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-02-03 07:47
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 20.9 KB
2024-12-02 02:03
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2024-11-06 01:53
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.1 KB
2024-10-11 03:52
Interim Report
半期報告書-第35期(2024/03/01-2025/02/28)
Japanese 254.6 KB

Automate Your Workflow. Get a real-time feed of all CREEK & RIVER Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CREEK & RIVER Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CREEK & RIVER Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.